Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 4 1Phase 1/2 1

Status

Completed 7Recruiting 5Active not recruiting 5Terminated 4Not yet recruiting 3Unknown 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Urinary Bladder Neoplasms 4Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Cystectomy × Clear all
NCT06290687 2026-05-07

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Case Comprehensive Cancer Center

Phase 2 Recruiting
40 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06263153 2025-12-17

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
24 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06091124 2025-12-08

NEOBLAST

RenJi Hospital

Phase 2 Recruiting
22 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06184516 2025-09-15

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

University of Florida

Phase 2 Recruiting
147 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT05312671 2025-06-29

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
63 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡